Exagen (NASDAQ: XGN) grants director options at $4.31 strike
Rhea-AI Filing Summary
EXAGEN INC. (XGN) director Bruce C. Robertson reported an award of a stock option covering 37,500 shares of common stock at an exercise price of $4.31 per share on June 9, 2026. The option expires on June 8, 2036 and becomes fully vested and exercisable on the earlier of the first anniversary of the grant date or the next annual stockholders’ meeting, contingent on his continued board service. Following this grant, he holds options on 55,500 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Robertson Bruce C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option(right to buy) F1 | 37,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option(right to buy) — 55,500 shares (Direct)
Footnotes (1)
- F1. The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Option shares granted: 37,500 shares
Exercise price: $4.31 per share
Underlying common shares: 37,500 shares
+3 more
6 metrics
Option shares granted
37,500 shares
Stock option award to Bruce C. Robertson on 2026-06-09
Exercise price
$4.31 per share
Conversion or exercise price of the granted stock options
Underlying common shares
37,500 shares
Common stock underlying the granted option
Options held after transaction
55,500 shares
Total option shares directly held by Bruce C. Robertson following the grant
Grant date
2026-06-09
Date of stock option award
Expiration date
2036-06-08
Expiration of the granted stock option
Key Terms
Stock Option(right to buy), exercise price, vested and exercisable, annual meeting of the Issuer's stockholders
4 terms
Stock Option(right to buy) financial
"security_title "Stock Option(right to buy)""
exercise price financial
"conversion_or_exercise_price of $4.3100 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested and exercisable financial
"becomes fully vested and exercisable on the first to occur"
annual meeting of the Issuer's stockholders financial
"or (b) the next occurring annual meeting of the Issuer's stockholders"
FAQ
What did XGN director Bruce C. Robertson report in this Form 4?
Bruce C. Robertson reported a grant of stock options for 37,500 shares of EXAGEN INC. common stock at an exercise price of $4.31 per share, expiring June 8, 2036, subject to vesting conditions.
What is the exercise price of the new stock options reported for XGN?
The new stock options have an exercise price of $4.31 per share. This is the price at which Bruce C. Robertson can purchase EXAGEN INC. common shares once the options vest and become exercisable.
When do Bruce C. Robertson’s new XGN options vest?
The options become fully vested on the earlier of one year from the June 9, 2026 grant date or the next annual meeting of stockholders, provided he continues serving on EXAGEN INC.’s board until that vesting date.
Is the Form 4 transaction for XGN a purchase or an award of options?
The Form 4 reports a grant/award of stock options, not an open-market share purchase or sale. The transaction uses code “A,” indicating an acquisition of derivative securities as compensation rather than a market trade.
AI-generated analysis. How Rhea-AI works. Not financial advice.
